# Ceftriaxone

## Ceft-S inj 1gm

| TAH Drug Code      | [ICEFS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICEFS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Infections caused by staphylococcus, streptococcus, pneumococcus, meningococcus, and other susceptible bacteria.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | For adults: 1-2g once daily. Severe infections: maximum 4g/day, divided into two doses. For neonates (up to 2 weeks old): 20-50mg/kg/day, maximum 50mg/kg. For infants and children (3 weeks-12 years old): 20-80mg/kg/day, administered once daily. (Sanford Guide) Adult - Usual: 1-2g IV q24h. Purulent meningitis: 2g IV q12h. Gonococcal urethritis: single dose of 500mg IM (if <150kg), 1g IM (if >=150kg). Meningococcal PEP (age >=15): single dose of 250 mg IM Pediatric - Age >28 Days: 50-100mg/kg q24h; Meningitis 50mg/kg q12h. Meningococcal PEP (age <15): 125mg IM x 1 dose |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Concurrent administration of calcium-containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition, in neonates aged 28 days or less due to risk of fatal salt precipitation in lungs and kidneys. Hyperbilirubinemic neonates, due to increased risk of bilirubin encephalopathy (kernicterus), especially in premature neonates. Hypersensitivity to cephalosporins. Pregnant women, especially during the first three months, should avoid using unless absolutely necessary.                                                                    |
| Adverse Effects    | Common: Injection site induration, Warmth, tightness, or induration (5-17%), Diarrhea (2.7-5.6%), Eosinophil count above reference range (6%), Thrombocytosis (5.1%) Serious: Erythema multiforme, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Clostridium difficile colitis, Hemolytic anemia (<1%), Neutropenia, Hypersensitivity reaction (2.7-3.3%), Kernicterus of newborn, Renal failure, Injury of lung                                                                                                                                                                      |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

